Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-2075-2014

Siemens syngo RT Dosimetrist 2.7 system Product Usage: The intended use of syngo Suite for Oncology Systems is as an accessory to the linear accelerator system to aid and support in the planning and delivery of x-ray radiation for the therapeutic treatment of cancer.

Publicado el 23 de julio de 2014 · Inicio del retiro: 15 de mayo de 2014

Resumen

FDA registra el retiro Z-2075-2014 de dispositivos médicos de Clase II, publicado el 23 de julio de 2014 e iniciado el 15 de mayo de 2014. Empresa responsable: Siemens Medical Solutions USA, Inc; Estado: Finalizado; Cantidad reportada: 7; Lote: material number: 10568604 , with serial numbers 10201 10231 10237 10266 10267 10305 10272. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

An update to the Virtual Simulation software of the syngo RT Dosimetrist is necessary to address a safety issue. In special scenarios within the Structure Operations function the system did not store the selected name from the list of predefined names. After reloading of the data, this structure name had been changed by the system. Additionally, a performance issue was addressed where import of DI

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Siemens Medical Solutions USA, Inc
Distribuidor
US Nationwide Distribution in the states of NH, TN, OH, VA, and TX.
Lote
material number: 10568604 , with serial numbers 10201 10231 10237 10266 10267 10305 10272
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Siemens syngo RT Dosimetrist 2.7 system Product Usage: The intended use of syngo Suite for Oncology Systems is as an accessory to the linear accelerator system to aid and support in the planning and delivery of x-ray radiation for the therapeutic treatment of cancer. fue retirado del mercado?

Sí. FDA publicó el retiro Z-2075-2014 el 23 de julio de 2014. Peligro reportado: An update to the Virtual Simulation software of the syngo RT Dosimetrist is necessary to address a safety issue. In special scenarios within the Structure Operations function the system did not store the selected name from the list of predefined names. After reloading of the data, this structure name had been changed by the system. Additionally, a performance issue was addressed where import of DI

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter